Indolent Systemic Mastocytosis
📧 Sign up to get email alerts when something new happens for Indolent Systemic Mastocytosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
The document reports expanded access for Bezuclastinib to patients with nonadvanced or advanced systemic mastocytosis.
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis [Phase 2]
This Phase 2 trial evaluated subcutaneous sarilumab for improving quality of life in people with indolent systemic mastocytosis; results hav…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment [Phase 3]
A Phase 3 trial of masitinib in severe Indolent Systemic Mastocytosis unresponsive to optimal symptomatic treatment is underway, with status…
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis [Phase 3]
Phase 3 clinical trial update for masitinib in indolent systemic mastocytosis has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Patient-Reported Outcome Questionnaire for Systemic Mastocytosis
A clinical trial update on a patient-reported outcome questionnaire for systemic mastocytosis, with the study status marked as completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: Treatment of Indolent Systemic Mastocytosis With PA101 [Phase 2]
A Phase 2 clinical trial evaluating PA101 for indolent systemic mastocytosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Midostaurin in Indolent Systemic Mastocytosis [Phase 2]
A Phase 2 clinical trial update for midostaurin in indolent systemic mastocytosis; current status is unknown.